Rapport Therapeutics, Inc. - RAPP

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$2.13B
QoQ value delta ($000)
+$487.9M (+29.71%)
Implied price effect (QoQ)
+32.77%
Shares
Total shares
51,305,900
QoQ shares delta
-1,211,531 (-2.31%)
Total shares held by funds (by quarter)

Market chart (RAPP)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 160 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 298,894 7,172,894 0.01%
TRV GP V, LLC 261,709 6,280,525 52.53%
ARCH Venture Management, LLC 155,376 3,728,738 14.12%
Capital International Investors 121,757 2,921,958 0.03%
GOLDMAN SACHS GROUP INC 121,278 2,910,449 0.01%
BlackRock, Inc. 112,500 2,699,786 0.0%
Cormorant Asset Management, LP 110,738 2,657,521 5.67%
Sofinnova Investments, Inc. 79,356 1,904,408 4.1%
JOHNSON & JOHNSON 74,360 1,784,517 9.31%
Polar Capital Holdings Plc 67,026 1,608,514 0.16%
BAKER BROS. ADVISORS LP 64,467 1,547,090 0.32%
VANGUARD CAPITAL MANAGEMENT LLC 56,109 1,346,512 0.0%
TRV GP VI, LLC 40,387 969,218 17.39%
STATE STREET CORP 34,115 818,712 0.0%
GEODE CAPITAL MANAGEMENT, LLC 33,068 793,453 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 32,814 787,446 0.0%
PERCEPTIVE ADVISORS LLC 32,225 773,342 0.48%
Vestal Point Capital, LP 30,419 730,000 0.71%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 26,838 644,082 0.0%
Siren, L.L.C. 26,730 641,469 0.54%
Capital World Investors 22,987 551,657 0.0%
ALLIANCEBERNSTEIN L.P. 21,695 693,384 0.01%
T. Rowe Price Investment Management, Inc. 16,385 393,200 0.01%
DIMENSIONAL FUND ADVISORS LP 15,087 362,114 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 14,998 359,944 0.0%